START Los Angeles — Los Angeles, California

START Los Angeles is a clinical research site located in Los Angeles, California, United States 90025.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

START Los Angeles has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer, Epidermal Growth Factor.

Sponsors: Aminex Therapeutics, Inc., EpiBiologics.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Los Angeles?

START Los Angeles has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Los Angeles conducted?

START Los Angeles has 2 clinical trials on record, with 2 currently active. Their work covers Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer, Epidermal Growth Factor.

Is START Los Angeles accredited by Crixeo Health?

START Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.